Suppr超能文献

双酚A口服最大允许剂量水平的推导。

Derivation of an oral Maximum Allowable Dose Level for Bisphenol A.

作者信息

Goodman Julie E, Peterson Michael K, Hixon Mary L, Pacheco Shubin Sara

机构信息

Gradient, 20 University Road, Cambridge, MA 02138, USA.

Gradient, 600 Stewart Street, Seattle, WA 98101, USA.

出版信息

Regul Toxicol Pharmacol. 2017 Jun;86:312-318. doi: 10.1016/j.yrtph.2017.03.024. Epub 2017 Apr 1.

Abstract

Bisphenol A (BPA) is a high production volume chemical that is used in plastics and epoxy coatings. In 2015, California's Office of Environmental Health Hazard Assessment (OEHHA) added BPA to the Proposition 65 list of chemicals "known to cause reproductive toxicity" based on its Developmental and Reproductive Toxicant Identification Committee's (DART-IC) conclusion that BPA has been shown to cause female reproductive toxicity. A critical factor in determining compliance with Proposition 65 is a Maximum Allowable Dose Level (MADL), which is the exposure level at which a chemical would have no observable reproductive effect even if a person were exposed to 1000 times that level. We performed a comprehensive review of the literature, including the studies reviewed by DART-IC, and derived an oral MADL. Of all the studies we identified, Delclos et al. (2014) is of sufficient quality, has the lowest no observed effect level (NOEL), and results in the most conservative MADL of 157 μg/d. This is generally supported by other studies, including those that were considered by DART-IC. Also, the oral MADL provides a similar margin of safety as OEHHA's dermal MADL and other regulatory guidelines. Taken together, the scientific data support an oral MADL of 157 μg/d.

摘要

双酚A(BPA)是一种大量生产的化学品,用于塑料和环氧涂料中。2015年,加利福尼亚州环境健康危害评估办公室(OEHHA)根据其发育和生殖毒性鉴定委员会(DART-IC)得出的双酚A已被证明会导致雌性生殖毒性的结论,将双酚A添加到《65号提案》中“已知会导致生殖毒性”的化学品清单中。确定是否符合《65号提案》的一个关键因素是最大允许剂量水平(MADL),即即使一个人接触到该水平的1000倍,化学品也不会产生可观察到的生殖影响的暴露水平。我们对文献进行了全面回顾,包括DART-IC审查的研究,并得出了口服MADL。在我们确定的所有研究中,德尔科斯等人(2014年)的研究质量足够高,未观察到影响水平(NOEL)最低,得出的最保守的MADL为157μg/天。这得到了其他研究的普遍支持,包括DART-IC考虑的那些研究。此外,口服MADL提供的安全边际与OEHHA的皮肤MADL和其他监管指南类似。综上所述,科学数据支持口服MADL为157μg/天。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验